Patent · US Active

Stable pharmaceutical foam

US11938165B2 · kind B2 · utility

0Cited by

11References

1Claims

0Family size

Assignees

Omrix Biopharmaceuticals Ltd. · IL
Ethicon, Inc. · US

Inventors

Tamar Auerbach-Nevo · Rehovot, IL
Ashley DeAnglis · Skillman, US
Israel Nur · Afula, IL

Key dates

Filing date	Aug 18, 2021
Grant date	Mar 26, 2024
Priority date	—
Expiry date	Dec 28, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2400/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.